In this issue:
Temozolomide or temozolomide and capecitabine for NETs
Adjuvant nab-paclitaxel gemcitabine in resected PDAC
Napabucasin plus nab-paclitaxel with gemcitabine for PDAC
NCCN genetic testing guidelines’ impact on treatment
mRNA vaccines stimulate T cells in pancreatic cancer
Efficacy of ICIs in MSI/dMMR PDAC
Neoadjuvant chemotherapy for pancreatic cancer
Algorithm to predict the risk of pancreatic cancer
Please login below to download this issue (PDF)